|Articles|October 1, 2006

Volume 0

MYLAN ACQUIRES INDIAN GENERIC DRUG MAKER MATRIX LABS

Mylan Laboratories moved into the international generic pharmaceutical market ina big way by announcing an agreement to acquire India's Matrix Labs. Under theagreement, Mylan will buy a 51.5% stake at Matrix under a complex formula thatcould drive the final cost as high as $736 million. Matrix Labs will remain a publiclytraded company in India and will continue to operate independently of Mylan.

Matrix Labs, one of the 12 companies authorized to supply medicines to formerPresident Bill Clinton's Clinton Foundation, is also one of India's leading suppliers ofraw materials for use by other generic pharmaceutical manufacturers in India.

Articles in this issue

about 19 years ago

Article

Equation for Success: Diabetes Medication, Diet, and Exercise

about 19 years ago

Article

Rx Product News

about 19 years ago

Article

OTC Product News

about 19 years ago

Article

can you READ these Rxs?

about 19 years ago

Article

Aggressive Management of Type 2 Diabetes to Prevent Macrovascular Complications

about 19 years ago

Article

Juvenile Anabolic Steroid Abuse

about 19 years ago

Article

Compounding Hotline

about 19 years ago

Article

RESPy AWARD: A Role Model for Pharmacy Students

about 19 years ago

Article

Ouch! Time for Flu Shots

about 19 years ago

Article

Supreme Court Declines to Review Generic Marketing Pacts

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Virtual Conference

Directions in Oncology Pharmacy® 2025: West Coast

Thursday, October 16, 2025

Webinar Registration

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

October 23, 2025 | 1:00 PM & 6:00 PM ET

On-Demand Webinar

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

1.25 Credits / Neurology

MYLAN ACQUIRES INDIAN GENERIC DRUG MAKER MATRIX LABS

Articles in this issue

Newsletter

Related Content

Pipeline Progress: Novel Antibodies Deliver Durable Responses Across Diseases

Condition Watch: Women's Health

UConn’s Medical Writing Certificate Program: It’s Just "Write"

Beyond the Counter: Expanding the Role of Pharmacists Through Education, Coaching, and Social Media

Pharmacy Policy Updates for October 2025

Latest CME

Directions in Oncology Pharmacy® 2025: West Coast

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine Uptake and Optimally Utilize Available Vaccines

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic Leukemia

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

Overview and Burden of Migraine

The Evolving Treatment Landscape of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

The Impact and Role of Pharmacists in the Management of Specialty Therapies

ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

The Role of the Pharmacist in the Management of Hyperlipidemia

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis

Improving Patient Outcomes in Seasonal and Perennial Allergic Conjunctivitis (Pharmacy Technician Credit)

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Beyond the Spots: Management of Measles

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

Evaluating the Role of Pharmacists in Utilizing Potassium-Competitive Acid Blockers for Acid Peptic Disorders

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Payment for Pharmacist Services: 2025 Update

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025?